|
1
|
Gandhi L and Johnson BE: Paraneoplastic
syndromes associated with small cell lung cancer. J Natl Compr Canc
Netw. 4:631–638. 2006.PubMed/NCBI
|
|
2
|
Poepel A, Jarius S, Heukamp LC, et al:
Neurological course of long-term surviving patients with SCLC and
anti-Hu syndrome. Neurol Sci. 263:145–148. 2007. View Article : Google Scholar
|
|
3
|
Hoffmann LA, Jarius S, Pellkofer HL, et
al: Anti-Ma and anti-Ta associated paraneoplastic neurological
syndromes: 22 newly diagnosed patients and review of previous
cases. J Neurol Neurosurg Psychiatry. 79:767–773. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cadavid D, Diaz JC, Masaru Shinchi A and
Jesualdo Ariza Y: Rapid, severe neurological impairment associated
with paraneoplastic cerebellar degeneration and anti-Yo antibodies.
Neurologia. 29:128–129. 2014. View Article : Google Scholar
|
|
5
|
Tani T, Tanaka K, Idezuka J and Nishizawa
M: Regulatory T cells in paraneoplastic neurological syndromes. J
Neuroimmunol. 196:166–169. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Carpenter EL, Vance BA, Klein RS, et al:
Functional analysis of CD8+ T cell responses to the onconeural self
protein cdr2 in patients with paraneoplastic cerebellar
degeneration. J Neuroimmunol. 193:173–182. 2008. View Article : Google Scholar
|
|
7
|
Blaes F: Paraneoplastic neurological
syndromes - diagnosis and management. Curr Pharm Des. 18:4518–4525.
2012. View Article : Google Scholar
|
|
8
|
Blomstrand C and Hamberger: A protein
turnover cell-riched factions from rabbit brain. J Neurochem.
16:1401–1407. 1969. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Towbin H, Staehelin T and Gordon J:
Electrophoretic transfer of proteins from polyacrylamide gels to
nitrocellurose sheets: procedure and some applications. Proc Natl
Acad Sci USA. 76:4350–4354. 1979. View Article : Google Scholar
|
|
10
|
Weissert R: The immune pathogenesis of
multiple sclerosis. J Neuroimmune Pharmacol. 8:857–866. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Johnson V, Friedman N, Haller NA and Hagel
C: Immune mediated neurologic dysfunction as a paraneoplastic
syndrome in renal cell carcinoma. J Neurooncol. 90:279–281. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hadjivassiliou M: Immune-mediated acquired
ataxias. Handb Clin Neurol. 103:189–199. 2012. View Article : Google Scholar
|
|
13
|
Sommer C, Weishaupt A, Brinkhoff J, et al:
Paraneoplastic stiff-person syndrome: passive transfer to rats by
means of IgG antibodies to amphiphysin. Lancet. 365:1406–1411.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hassan KA, Kalemkerian GP and Trobe JD:
Long-term survival in paraneoplastic opsoclonus-myoclonus syndrome
associated with small cell lung cancer. J Neuroophthalmol.
28:27–30. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tanaka K: A study on pathomechanisms of
paraneoplastic neurological syndrome. Rinsho Shinkeigaku.
41:1150–1152. 2001.(In Japanese).
|
|
16
|
Fukami Y, Umemura T, Shimono T, Yokoi T,
Kamijo M and Sakakibara T: Following sensory neuropathy, anti-Hu
antibody-positive paraneoplastic neurological syndrome presenting
with limbic encephalitis occurs after complete remission. Rinsho
Shinkeigaku. 53:287–292. 2013.(In Japanese). View Article : Google Scholar
|
|
17
|
Rauer S and Andreou I: Tumor progression
and serum anti-HuD antibody concentration in patients with
paraneoplastic neurological syndromes. Eur Neurol. 47:189–195.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Douglas CA and Ellershaw J: Anti-Hu
antibodies may indicate a positive response to chemotherapy in
paraneoplastic syndrome secondary to small cell lung cancer.
Palliat Med. 17:638–639. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wymenga AN, Slebos DJ, van der Naalt J,
van Putten JW and Peters FT: Abdominal complaints and neurological
symptoms as an early sign of lung cancer: a manifestation of the
anti-Hu syndrome. Ned Tijdschr Geneeskd. 147:616–619. 2003.(In
Dutch). PubMed/NCBI
|
|
20
|
Mannering SI, Morris JS, Jensen KP, et al:
A sensitive method for detecting proliferation of rare autoantigen
- specific human T cells. J Immunol Methods. 283:173–183. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Karagöz B, Bilgi O, Gümüs M, et al:
CD8+CD28− cells and
CD4+CD25+ regulatory T cells in the
peripheral blood of advanced stage lung cancer patients. Med Oncol.
27:29–33. 2010. View Article : Google Scholar
|
|
22
|
Pranzatelli MR, Travelstead AL, Tate ED,
et al: Immunophenotype of blood lymphocytes in
neuroblastoma-associated opsoclonus-myoclonus. Pediatr Hematol
Oncol. 26:718–23. 2004. View Article : Google Scholar
|
|
23
|
Hayashi Y and Inuzuka T: Paraneoplastic
neurological syndrome and autoantibodies. Brain Nerve. 65:385–393.
2013.PubMed/NCBI
|
|
24
|
de Graaf M, de Beukelaar J, Bergsma J, et
al: B and T cell imbalances in CSF of patients with Hu-antibody
associated PNS. J Neuroimmunol. 195:164–170. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Billet SE, Grando SA and Pittelkow MR:
Paraneoplastic autoimmune multiorgan syndrome: review of the
literature and support for a cytotoxic role in pathogenesis.
Autoimmunity. 39:617–630. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sehgal VN and Srivastava G: Paraneoplastic
pemphigus/paraneoplastic autoimmune multiorgan syndrome. Int J
Dermatol. 48:162–169. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Trier NH, Hansen PR, Vedeler CA, Somnier
FE and Houen G: Identification of continuous epitopes of HuD
antibodies related to paraneoplastic diseases/small cell lung
cancer. J Neuroimmunol. 243:25–33. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
de Jongste AH, de Graaf MT, Martinuzzi E,
et al: Three sensitive assays do not provide evidence for
circulating HuD-specific T cells in the blood of patients with
paraneoplastic neurological syndromes with anti-Hu antibodies.
Neuro Oncol. 14:841–848. 2012. View Article : Google Scholar : PubMed/NCBI
|
